INTRODUCTION
Choroid plexuses (ChPs) are heavily vascularized secretory organs in the brain, which serve as sites of cerebrospinal fluid (CSF) production and are also known to generate chemicals and polypeptides with neuroprotective, surveillance and repair functions. The ChP epithelium has been the focus of extensive studies, as it serves as the blood-CSF barrier (Redzic et al., 2005; Segal, 2000) . ChPs originate from four focal sites at the roof of the brain ventricles: two in the lateral ventricles of the telencephalon, one in the third ventricle of the diencephalon and one in the fourth ventricle of the hindbrain (hChP). Among all ChPs, hChP emerges earliest during embryogenesis and is conspicuously large. Outgrowth of the hChP is clearly evident at E12.5 as a pair of bilateral ridges protruding from the roof of the hindbrain, gradually developing into a highly convoluted organ with extensive epithelial folding. hChP consists of an outer epithelial layer and an inner core of stromal cells that are surrounded by a dense vascular network. The hChP epithelium (hChPe) initially emerges as a single sheet of pseudostratified cells, but by E13.5 the hChPe adopts a simple columnar morphology with numerous microvilli at the surface (Sturrock, 1979) . Previous studies suggest that the rhombic lip, a germinal zone, first gives rise to the hindbrain roof plate epithelium (hRPe), which is further specified, potentially by high levels of Bmp signaling (Hebert et al., 2002) , into definitive hChPe (Thomas and Dziadek, 1993) . Genetic fate-mapping studies have shown that hChPe cells are derived from progenitor cells residing in the anterior lower rhombic lip (LRL), which is positioned between the developing hChP and medulla, with the expression of secreted growth factors Wnt1, Gdf7 and LIMdomain transcription factor Lmx1a (Awatramani et al., 2003; Chizhikov et al., 2006; Currle et al., 2005) . A recent study indicates that Wnt1-expressing LRL cells can directly contribute to hChPe from E10 to E14 but this contribution ceases around E14 (Hunter and Dymecki, 2007) . However, continued growth of the hChP beyond E14 suggests contribution by other hChPe progenitor sources besides early contribution by the hRPe and anterior LRL.
The Shh gene encodes a secreted signaling molecule that is indispensable for animal development. Patched 1 (Ptch1), a 12-pass transmembrane receptor for Shh, functions as a negative regulator of Shh signaling by suppressing the activity of a 7-pass transmembrane protein, Smoothened (Smo) . Shh binding to Ptch1 relieves Smo from inhibition, hence triggering Shh signaling and subsequent activation of downstream target gene expression mediated by the Gli family of transcription factors (Ingham and McMahon, 2001) . Gli1 is the only member whose expression is directly regulated by Shh signaling at the transcriptional level and, like Ptch1 expression, it serves as a direct readout of Shh pathway activation (Ahn and Joyner, 2004; Goodrich et al., 1996) .
In the central nervous system (CNS), Shh is well recognized for its role in patterning different ventral neuronal cell types during early embryogenesis and in promoting cerebellar granule precursor cell proliferation (Goodrich et al., 1997; Wallace, 1999; Dahmane and Ruiz i Altaba, 1999; Wechsler-Reya and Scott, 1999) . However, the role of Shh signaling during early embryonic CNS development is largely confined to the ventral regions. Interestingly, a recent study reported that Shh functions as an indispensable mitogen during dorsal telencephalic development (Komada et al., 2008) . Nevertheless, a definitive dorsal role of Shh has not been generally appreciated. Here we have identified a distinct proliferating hChPe progenitor domain, adjoining the anterior LRL, displaying Shh signaling. Although direct contribution to the hChPe by cells of the LRL may have ceased by E14 (Hunter and Dymecki, 2007) , our finding indicates that Shh signaling promotes proliferation of cells in the hChPe progenitor 
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Choroid plexuses (ChPs) are vascularized secretory organs involved in the regulation of brain homeostasis, and function as the blood-cerebrospinal fluid (CSF) barrier. Despite their crucial roles, there is limited understanding of the regulatory mechanism driving ChP development. Sonic hedgehog (Shh), a secreted signal crucial for embryonic development and cancer, is strongly expressed in the differentiated hindbrain ChP epithelium (hChPe). However, we identify a distinct epithelial domain in the hChP that does not express Shh, but displays Shh signaling. We find that this distinct Shh target field that adjoins a germinal zone, the lower rhombic lip (LRL), functions as a progenitor domain by contributing directly to the hChPe. By conditional Shh mutant analysis, we show that Shh signaling regulates hChPe progenitor proliferation and hChPe expansion through late embryonic development, starting around E12.5. Whereas previous studies show that direct contribution to the hChPe by the LRL ceases around E14, our findings reveal a novel tissue-autonomous role for Shh production and signaling in driving the continual growth and expansion of the hindbrain choroid plexus throughout development.
domain, and thus contributes to the continual growth and expansion of the dorsally situated hChP throughout embryonic development.
MATERIALS AND METHODS

Mice
Wnt1-Cre (Jiang et al., 2000) , Gdf7-Cre (Lee et al., 2000) , Shh fl/fl (Lewis et al., 2001) , SmoM2 (Jeong et al., 2004) , Ptch1
LacZ/+ (Goodrich et al., 1997) , Gli1-Cre ERT2 (Ahn and Joyner, 2004) , ROSA26-LacZ (Soriano, 1999) and ROSA26-eYFP (Srinivas et al., 2001 ) mice have been described previously.
Immunohistochemistry
All immunohistochemistry analyses were performed on tissue sections collected from OCT-or paraffin-embedded embryos as previously described (Huang et al., 2007) . Primary antibodies were rabbit anti-Shh (Santa Cruz Biotechnology, 1:1000), rabbit anti-β-Gal (Cappel, 1:100), rabbit antiaquaporin 1 (Chemicon, 1:500), rabbit anti-Lmx1a (gift of Dr Michael German, UCSF, San Francisco, CA, USA; 1:200), mouse anti-BrdU (Roche Diagnostics, 1:50), rabbit anti-GFP (Molecular Probes, 1:500) and rabbit anti-cleaved caspase 3 (Cell Signaling Technology, 1:100).
Analysis of cell proliferation and apoptosis
Bromodeoxyuridine (BrdU) in vivo labeling and terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) analyses were performed as previously described (Huang et al., 2007) .
Cell imaging, counting and statistics
Confocal microscopy was performed on immunofluorescent-stained sections with 1 μm optical slices. Independent stainings were performed on at least three animals for each marker and at least ten nonoverlapping sections were counted to generate statistical comparisons. For a 1-hour short-term BrdU pulse, Lmx1a + ; BrdU + cells in the developing hChP region were located between the LRL and Aqp1-expressing differentiated hChPe. For quantifying proliferating hChPe progenitor cell numbers shown in Figs 3 and 6, and Fig. S4 in the supplementary material, the total number of Lmx1a + ; BrdU + cells that spanned the putative hChPe progenitor domain adjoining the anterior LRL, identified by a characteristic bulge, was counted. For quantifying the number of BrdU + cells after a 3-day pulse, contributing to the maturing hChPe shown in Fig. 4 
Tamoxifen treatment for temporal fate-mapping studies
Tamoxifen powder (Sigma T-5648) was dissolved in corn oil (Sigma C-8267) at a final concentration of 20 mg/ml. Pregnant females with E13 or E15 embryos from matings between Gli1-Cre ERT2 and ROSA26-LacZ or ROSA26-eYFP conditional and reporter mice, respectively, were each intraperitoneally injected with 4 mg tamoxifen. Females with E15 embryos were reinjected with 4 mg tamoxifen at E17. Embryos were then harvested and genotyped at E16 (injection at E13) and at newborn stage (P0) for injections at E15 and E17. Gli1-Cre
ERT2
; ROSA embryos were processed for β-galactosidase activity or YFP staining, which was followed by confocal microscopy.
X-Gal staining and transcript detection
X-Gal staining for β-galactosidase was performed according to standard protocols. The following cDNAs were used as templates for synthesizing digoxigenin-labeled riboprobes: Shh, Gli1, Ptch1, Ptch2, Gli3, Ttr, Bmp4, Msx1, Tgfb1, Tgfb3, spry1 and spry2.
RESULTS
Shh expression and signaling fields in the hindbrain choroid plexus
The hChP is generated bilaterally, protruding into the fourth ventricle, and is clearly evident at E12.5 (Fig. 1A,B) . It undergoes dramatic growth and expansion as development progresses and joins at the midline ( Fig. 1D-I ). By E16.5, the hChP has developed into a highly convoluted epithelial structure enveloping a vascularized stroma (Fig. 1G,H) . We observed strong Shh mRNA expression in the developing hChP epithelium (hChPe) starting at E12.5, and its expression persisted through to E18.5, the latest RESEARCH ARTICLE Development 136 (15) stage analyzed (Fig. 1C,F,I ; data not shown). In agreement, Shh protein is also highly expressed in the hChPe, with localization to both the apical and basolateral sides (Fig. 1J ,K,L). Interestingly, a small subset of hChPe cells appeared to express low or no Shh transcript at various developmental stages (red arrows in Fig. 1C and Fig. S1 in the supplementary material). We detected strong Shh signaling in the underlying hChP mesenchyme (hChPm), as shown by the expression of Shh signaling targets Gli1 and Ptch1 (Fig. 1M,N,O; Fig. S1 in the supplementary material) . Notably, we also identified a novel Shh target field within the developing hChP region, a restricted epithelial domain intercalated between the anterior LRL and the differentiated hChPe ( Fig. 1; Fig. S1 in the supplementary material, red dotted lines). This Gli1 + hChPe domain does not express Shh (arrows in Fig. 1C,J; Fig. S1 in the supplementary material). By contrast, the differentiated hChPe expresses Shh but does not display apparent Shh signaling activity ( Fig. 1; Fig. S1 in the supplementary material, black dotted lines). We did not detect Ptch2 expression in the developing hChP, whereas its expression was readily detected in the hair follicles (see Fig. S2 in the supplementary material) (Motoyama et al., 1998) . Interestingly, Gli3, a transcriptional repressor in the absence of Shh pathway activity, is expressed in the adjoining LRL but excluded from the putative hChPe progenitor domain (Fig. 1P) . We barely detected Gli1 signal in the telencephalic and diencephalic ChP regions at various developmental stages (data not shown), consistent with the fact that during embryogenesis only the hindbrain ChP expresses Shh, whereas the telencephalic and diencephalic ChPs do not (Tannahill et al., 2005 ) (data not shown).
Conditional abrogation of Shh signaling in Wnt1-Cre; Shh fl/-mutants leads to impaired hChP development To determine the functional role of Shh signaling during hChP development, we employed the Cre/loxP strategy to conditionally remove Shh in the hChPe. Previous genetic fate-mapping studies indicated that the hChP consists entirely of descendants of Wnt1-expressing cells that localize to the LRL (Hunter and Dymecki, 2007) . Indeed, we detected β-galactosidase activity uniformly in the hChPe when the Wnt1-Cre driver line was crossed to the ROSA26-LacZ reporter strain ( Fig. 2A,B) . Therefore, the Wnt1-Cre driver line is suitable for deleting Shh in the hChPe. The effectiveness of Wnt1-Cre deletion of Shh was confirmed by essentially ablating Shh and Gli1 expression in the fl/-mutant hChPe maintained its molecular identity, as evidenced by the expression of the differentiated hChPe marker transthyretin (Ttr) and water channel aquaporin 1 (Aqp1), expressed apically ( Fig. 2I-L) . Furthermore, abrogating Shh signaling in the hChP did not appear to alter its ability to produce other growth factors, such as Bmp4 and Tgfb3 in the hChPe or Tgfb1 in the hChPm ( Fig. 2M-P ; data not shown). The Fgf signaling pathway does not appear to regulate 2537 RESEARCH ARTICLE Shh signaling in the choroid plexus hChP development directly, as we did not detect appreciable expression of sprouty 1 and 2, which are target genes of the Fgf signaling pathway (Minowada et al., 1999 ) (see Fig. S2 in the supplementary material). These findings indicate that the growth defects seen in Wnt1-Cre; Shh fl/-mutant hChP are primarily due to the inability to perceive Shh signaling. Therefore, Shh production in the differentiated hChPe domain and Shh signaling within the hChP, including the distinct epithelial domain adjoining the LRL, are crucial for hChP development.
Shh signaling promotes proliferation of a distinct hChP epithelial progenitor domain Next, in order to elucidate the molecular mechanism of hChPe growth during development, we focused on determining the function of Shh signaling in the hChP epithelial target field. As mentioned above, whereas the Gli1 -differentiated hChPe expressing Aqp1 did not appear to display Shh signaling ( Fig. 1; Fig. 3A ,B, black dotted lines), we observed distinct Shh signaling (Gli1 + ) in a restricted epithelial domain adjoining the anterior edge of the LRL extending towards the hChPe (Fig. 1M ,N,O; see Fig. S1 in the supplementary material; Fig. 3A ,B, red dotted lines). As we observed a marked reduction in hChP growth in Wnt1-Cre; Shh fl/-mutants, we asked whether this Gli1 + hChPe region defined an hChPe progenitor domain, and we used Lmx1a expression to mark all cells in the hChPe (Chizhikov et al., 2006) . Indeed, in Ptch1
LacZ/+ embryos the β-Gal + Shh signaling domain overlapped with the Lmx1a-expressing domain adjoining the LRL (Fig. 3C-I , white arrows in E,F; G-I correspond to the red boxed region shown in C), indicating that Shh signaling occurred in this crucial domain. We determined that this specific Lmx1a + hChPe domain also displayed proliferative activity, as indicated by its rapid incorporation of BrdU and expression of Ki67 (Mki67 -Mouse Genome Informatics) ( Fig. 3J-M ; data not shown). By contrast, the rest of the hChPe was Ptch1 -and Gli1 -( Fig. 1M-O ; Fig. 3A,B; Fig. S1 in the supplementary material, black dotted lines) and postmitotic, as these cells did not show BrdU incorporation (after a 1-hour short-term pulse) or Ki67 expression ( Fig. 3J-M ; data not shown). Therefore, we propose that Shh pathway activity in the proliferating domain is a distinct hChPe domain harboring progenitor cells, which gives rise to nascent differentiated hChPe as development progresses. In agreement, we observed more than a 2-fold reduction in proliferating cells in this hChPe progenitor region in Wnt1-Cre; Shh fl/-mutants compared RESEARCH ARTICLE Development 136 (15) DEVELOPMENT with controls at E12.5 (44.4±8.5% versus 100±11.7%, P<0.001, n=3; Fig. 3J,K,N) , and a more pronounced decline in BrdU + cells (~7-fold) at E14.5 (15.3±5.2% versus 100±18.3%, P<0.001, n=3; Fig. 3L,M,N) .
We have also generated conditional Gdf7 Cre/+ ; Shh fl/-mutants using mice with Cre expression driven by the endogenous Gdf7 promoter, which is expressed in all of the ChPe (Currle et al., 2005) . However, we found that the knock-in Gdf7
Cre/+ line (Lee et al., 2000) is not as robust as the transgenic Wnt1-Cre line (Jiang et al., 2000) in driving complete Shh deletion in the hChPe (see Fig.  S4 in the supplementary material) . In agreement, we observed a relatively milder, but significant, hChP phenotype in Gdf7
Cre/+ ; Shh fl/-compared with Wnt1-Cre; Shh fl/-mutants at E14.5 (compare Fig. S4 in the supplementary material with Fig. 3) Fig. 3O-R) , even though apoptotic signals in the same sections were detected in peripheral nerve or muscle tissues between the developing ribs (see Fig. S3 in the supplementary material). Previous studies have shown direct LRL cell contribution to the hChPe but production appears to cease around E14. Here, we reveal the essential role of Shh signaling in promoting the proliferation of a distinct pool of hChPe progenitor cells in a domain adjoining the LRL, starting at ~E12.5 through late embryonic development, for the continual expansion of the hChP.
Shh signaling promotes proliferation of hChPe progenitor cells and hChPe biogenesis
To further define the role of Shh signaling in the production of hChPe cells, we performed BrdU pulse-chase labeling, for short and long periods, to compare the temporal contribution of nascent epithelial cells to the hChPe. By colabeling 1-hour-pulsed BrdU with the differentiated hChPe apical marker Aqp1, we observed a BrdU -Aqp1 -region between the hChPe progenitor and differentiated hChPe domains (Fig. 4A,AЈ) . Ki67 and Aqp1 double labeling demonstrated that this 'gap' region is nonmitotic (Fig.  4C,D) . After a 24-hour pulse, the BrdU + cells had migrated to the region just adjoining the Aqp1 + domain (Fig. 4B ,BЈ, white arrow), suggesting a rather slow rate of progenitor contribution to the hChPe. However, after a 3-day BrdU pulse, starting at E13.5 or 14.5, we observed an extensive contribution of nascent BrdU + cells well into the differentiated hChPe (Fig. 4E,G,I ). The BrdU + cell contribution to the hChPe in Wnt1-Cre; Shh fl/-mutants was evidently decreased by ~5-fold compared with controls upon analysis at E16.5 (22.1±4.8% versus 100±20.5%, P<0.001, n=3) ( Fig. 4E -H,K) and E17.5 (24.6±7.5% versus 100±15.2%, P<0.001, n=3) (Fig. 4I-K) . These results clearly indicate that hChPe progenitor proliferation in mutants had been compromised in the absence of Shh signaling.
To follow the fate of Gli1 + cells in the hChPe progenitor domain, we performed tamoxifen injections on pregnant females from matings between Gli1-Cre ERT2 and ROSA-LacZ or ROSA-eYFP reporter mice at E13, or E15 and E17, respectively, and harvested embryos at E16 or P0. These temporal fate-mapping studies demonstrated that, indeed, cells derived from the Gli1 + hChPe progenitor domain are incorporated into the mature hChPe (Fig. 5A-D, arrows) . The later-stage tamoxifen injection appeared to label fewer cells in the hChPe, consistent with our finding that the 2539 RESEARCH ARTICLE Shh signaling in the choroid plexus 
Lmx1a
+ hChPe progenitor domain displayed reduced proliferative activity at late developmental and postnatal stages ( Fig. 6 ; data not shown). We observed extensive Gli1-Cre activated gene recombination in the cerebellar external granule layer in the same embryo, indicating the efficacy of tamoxifen treatment (see Fig. S5 in the supplementary material). As tamoxifen usually begins to be effective in driving gene recombination ~12-24 hours postinjection, our data reveal that Gli1-expressing cells between ~E14 and E18 within the hChPe progenitor domain continue to be incorporated into the expanding hChPe. Taken together, these data demonstrate that Shh signaling is required to maintain a pool of proliferating cells in the hChPe progenitor domain and that these Gli1 + cells appear to contribute to hChPe expansion beginning at ~E12.5 through to late developmental stages.
To further support the crucial proliferative role of Shh signaling during hChPe development, we generated Wnt1-Cre; SmoM2 and Gdf7
Cre/+ ; SmoM2 mutants, in which constitutively active SmoM2 (Jeong et al., 2004 ) is expressed in all hChPe cells. As Wnt1-Cre is also expressed in the neural crest lineage and widespread Shh pathway overactivation led to profound craniofacial and neural tube defects, including excencephaly, all subsequent analyses were performed using the Gdf7
Cre/+ driver line. Interestingly, although ectopic Notch signaling has been reported to elicit persistent proliferation in many mature hChPe cells (Dang et al., 2006; Hunter and Dymecki, 2007) , we observed enhanced mitotic activity that appeared to be confined to the putative hChPe progenitor region adjoining the anterior LRL in Gdf7 Cre/+ ; SmoM2 mutants at E14.5 and at birth (Fig. 6) . After a 1-hour pulse, we did not observe BrdU + cells within the Aqp1-expressing differentiated hChPe in either controls or Gdf7
Cre/+ ; SmoM2 mutants (Fig. 6F,G) . This observation suggests distinct regulatory mechanisms by which the Notch and Shh pathways expand the hChPe cell population. Although the number of proliferating Lmx1a + hChPe progenitor cells appeared to dwindle at birth (Fig. 6C,D) , we observed enhanced proliferative activity in the hChPe progenitor domain in Gdf7
Cre/+ ; SmoM2 mutants compared with controls at E14.5 (188.8±21.1% versus 100±10.9%, P<0.001, n=3) (Fig. 6A-BЉ,E) and P0 (161.2±25.9% versus 100±25.4%, P<0.001, n=3) (Fig. 6C-E) . These gain-offunction studies further support our finding that Shh signaling is both necessary and sufficient to drive proliferation of hChPe progenitor cells.
Most Gdf7 Cre/+ ; SmoM2 mutants do not survive beyond 3 weeks after birth. All mutants were runted and exhibited neurological defects reflected by their relative immobility compared with control littermates. Consistent with enhanced proliferation at the progenitor domain, the hChPs of Gdf7
Cre/+ ; SmoM2 mutants appeared larger in size, displaying more epithelial foldings (Fig. 7) . ChPs of the diencephalon and telencephalon might also be affected by expression of SmoM2, as the Gdf7 lineage maps to these choroid plexus epithelia. Therefore, the severe phenotype of Gdf7
Cre/+ ; SmoM2 mutant neonates might be due to the combined aberrant function of ChPs and disruption in CNS homeostasis.
DISCUSSION
ChPs are secretory organs in the brain; they serve as sites of CSF production and function as blood-CSF barriers to maintain CNS homeostasis. Although Bmp signaling in the dorsal midline has been implicated in the specification of ChP epithelial fate (Cheng et al., 2006; Hebert et al., 2002) , signaling mechanisms that regulate ChP epithelium production and expansion remain poorly understood. It has been reported that the hChP expresses many morphogens, such as Bmps, Fgfs, Tgfβs and Shh (Bitgood and McMahon, 1995; Emerich et al., 2005; Redzic et al., 2005) . However, surprisingly little is known about the developmental mechanism or molecular pathway that regulates hChP biogenesis. Interestingly, choroid plexus tumor is a pediatric neoplasm characterized by uncontrolled growth of the ChP epithelium, and 40% of ChP tumors arise in the hindbrain ventricle (Gopal et al., 2008) . Considering that Shh expression in the CNS is restricted to the ventral axial midline of the floor plate and the neuroectoderm before/at mid-gestation, it is quite unique that a dorsal roof-plate-derived hChP exhibits robust Shh expression. Here we show that Shh signaling plays an essential role in regulating hChPe progenitor cell proliferation and, thus, expansion of the hChP throughout embryogenesis (Fig. 8) .
The hChP exhibits complex epithelial folding during development that vastly enlarges its surface area necessary for secretory functions. Therefore, it is essential to ensure adequate production of epithelial cells throughout hChP development. Previously, Bmp signaling has been found to specify the primitive pseudostratified epithelial domain into a definitive ChPe fate, demonstrated by the specific loss of ChP after telencephalic inactivation of the Bmp receptor Bmpr1a (Hebert et al., 2002) .
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Development 136 (15) Genetic fate-mapping studies suggested that the hChPe progenitor resides in the anterior LRL domain expressing Gdf7 and Lmx1a. The Notch signaling pathway has been shown to promote hChPe proliferation, as retrovirus-driven expression of the ligand Notch3 (Dang et al., 2006) and Gdf7 Cre -driven ectopic expression of the activated ligand Notch1
ICD (Hunter and Dymecki, 2007) both led to the persistent proliferation of hChPe cells. Conversely, global inactivation of Notch signaling in zebrafish resulted in defective ChP development (Bill et al., 2008; Garcia-Lecea et al., 2008) . However, these overexpression and global gene inactivation analyses yielded limited information on whether Notch signaling regulates the proliferative capacity of hChPe progenitor domain in a physiologically unperturbed situation, and what cell population Notch signaling directly targets. Indeed, we observed that Notch1 2541 RESEARCH ARTICLE Shh signaling in the choroid plexus expression encompasses the entire LRL (X.H. and C.C., unpublished), indicative of a broader function of Notch signaling rather than Notch specifically acting on expanding the hChPe progenitor domain.
Here, our study identifies a Shh signaling hChPe progenitor domain adjoining the anterior LRL. Loss-and gain-of-function analyses demonstrated that Shh signaling functions specifically to promote proliferation of this hChPe progenitor domain to ensure sufficient production of nascent hChPe cells that gradually get incorporated into the medial differentiated hChPe. Therefore, we propose that Shh signaling defines a novel Lmx1a + hChPe progenitor domain, and Shh pathway activation is essential for regulating the proliferation of these progenitor cells, which is crucial for hChP biogenesis from ~E12.5 through to late stages of development.
The finding that Shh signaling promotes the proliferation of epithelial progenitor cells destined to become part of the hChPe, which is itself a primary source of the Shh ligand, reveals an interesting biological phenomenon in which the Shh target and producing cells are part of the same tissue, the ependymal epithelium. We show that Shh produced in the hChPe not only signals to the mesenchyme, a classic example of an epithelialmesenchymal interaction, but also to its own progenitor domain, and is thus a unique example of two distinct target fields within one organ (Fig. 8) . In several endoderm-derived organs displaying epithelial-mesenchymal interactions, it is thought that Shh produced by the epithelium exclusively signals to the mesenchyme, which in turn generates another mitogenic signal to promote epithelial proliferation. Although the hChP mesenchyme could also contribute to hChPe growth, our finding reveals a tissue-autonomous role of hChPe with regard to Shh production and signaling in driving the growth and expansion of a conspicuously large hindbrain choroid plexus.
